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OSTEOPOROSIS AND PATHOLOGICAL FRACTURES FOLLOWING
TREATMENT WITH ACTH AND CORTISONE*
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The profound alterations in tissue electrolytes which may occur during ACTH
and cortisone therapy have been the subject of numerous reports (1—3). For
the most part, these have emphasized the disturbances of sodium and potassium
metabolism. The effects on calcium, phosphorus, and alkaline phosphatase
during corticosteroid administration have received less attention. Definite re-
tardation of chondrogenesis and osteogenesis has been observed in rats given
ACTH (4), and Blunt et al (5) have described the poor healing of fractures in
the experimental animal receiving cortisone. In man, an increased urinary and
fecal excretion of calcium and phosphorus, as well as a fall in the serum con-
centrations of these substances, has been noted during treatment with these
hormones (1, 6).
Since most of the clinical features of Cushing's syndrome have been en-
countered during the course of ACTH or cortisone therapy, it has been expected
that the osteoporosis and fractures characteristic of this condition would occur
in patients treated with these hormones for prolonged periods of time. Thus far,
however, only one report stressing the osseous complications of ACTH and
cortisone therapy has appeared, and this deals with pathological fractures in
patients with rheumatoid arthritis, a disease in which osteoporosis and even
fractures may occur in the usual course of events (7). All of these cases showed
some degree of osteoporosis before the administration of corticosteroids with a
rapid acceleration of the process thereafter.
The following case under our care illustrates the development of these serious
osseous complications in a patient with pemphigus vulgaris whose skeletal
survey was normal before ACTH and cortisone therapy.
E. M., a white man aged 48, has had pemphigus vulgaris of the skin and mucous mem-
branes since 1948. An initial favorable response to supportive treatment, supplemented by
aureomycin, naphuride and irradiation of the liver and spleen in early 1949, was soon
followed by a severe relapse. In July 1949 he was moribund At that time ACTH was ad-
ministered and the clinical improvement was dramatic. Radiographs of the verte-
bral column in October 1949 showed no bony abnormalities (Fig. 1). Since 1949 the patient
has been maintained on almost continuous treatment with ACTH or cortisone. His course
has been characterized by several exacerbations and remissions and a satisfactory constant
dose of corticosteroids, capable of maintaining a complete clinical remission, has never been
established.
Since May 1950, the patient has shown evidences of hyperadrenalism in the form of in-
creased pigmentation, moon facies, poikilodermatous changes in the skin, gynecomastia,
* From the Department of Dermatology, College of Physicians and Surgeons, Columbia
University, and the Vanderbilt Clinic, Presbyterian Hospital, New York City.
The cortisone used in this study was supplied through the courtesy of Merck and Com-
pany, Inc. Rahway, N. J.
Received for publication April 23, 1952.
205
206 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
elevated blood pressure, and a redistribution of body fat toward the buffalo-hump type.
The prompt reappearauce of bullae upon eessatiou of cortieosteroid therapy has necessi-
tated continuons administration of the hormones.
In May 1951, after receiving a total of 41,650 mg. of cortisone and 4,135 mg. of ACTH,
X-ray films of the spine revealod deniineralization of the vertebral column. Calcium and
testosterone were then given in the hope of rctarding the process. In June 1951, the patient's
pemphigus seemed to he escaping from cortisone control and he was started on ACTH.
Further radiographic studies in August 1951 revealed no change in the vertebral osteo-
Fm. 1. Radiograph of E M. (October 1949) showing no osteoporosis and no bony ab-
normalities of vertebral bodies.
porosis (Fig. 2a and 2b). An explosive outbreak of the lesions while on ACTH intramuscu-
larly necessitated the simuItaneou administration of cortisone and intravenous ACTR.
Before the eruption was finally brought under control, 22,325 mg. of cortisone and 1,100
mg. of ACTR had been given. 19,000 mg. more of cortisone was administered in the next
three months on an ambulatory basis with excellent control of the patient's eruption except
for the mouth lesions. In December 1951, the patient suddenly complained of severe low
back pain with inability to stand or straighten his back. Roentgenograms were interpreted
as showing no essential change from the previous examination. Two thonths later, however,
additional radiographs showed extension of the previously noted osteoporosis with collapse
and "codfishing" of all vertebral bodies from the ninth thoracic to the fifth lumbar (Fig.
3a and 3b). Serum calcium at this time was 8.8 mg. per cent, phosphorus 3.7 mg. per cent,
and alkaline phosphatase 4.3 Bodansky Units.
Fiu. 2a
FIG. 2b
FIGS. 2a AND 2b. Diffuse demineralization of the spine after 25 months of ACTH and
cortisone therapy.
207
.4 N:I
208 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
COMMENT
Osteoporosis is a well-known part of Cushiag's syndrome. Aibright ascribed
it to excessive adrenal S hormone, the anti-anabolic hormone (identical with
Compound E) (8). Others have noted this osteoporosis as well as increased
urinary and fecal excretioa of calcium and phosphorus in pituitary basophilism
(9). Sussman and Copleman (10) reported roentgeaographic changes in six of
Fio. 3a
FIGs. 3a AND 3b. Multiple compression defects and "eodfishing" nf vertebral bodies after
31 months of ACTH and cortisone therapy. Herniation of nucleus pulposus into the softened
vertebral bodies is visible.
seven cases of Cushing's syndrome consisting of osteoporosis, vertebral com-
pression defects and "codfishing," identical with the lesions seen in our patient.
The development of a temporary Cushing-like picture following ACTII or
cortisone is well documented (11). The similarities extend further than the skin.
In these "artificial" cases of hyperadrenalism the same hormonal factors are
operating as in the "natural" cases to cause increased calcium and phosphorus
loss with subsequent osteoporosis and fracture. The basic mechanism seems to be
related to protein breakdown with release of protein-bound calcium. Apparently
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the problem is not so much one of calcium deposition iii the bony matrix as it is
matrix formation. Lowered activity of osteoblasts and other cells concerned with
bone formation has been implicated (7).
Attempts to correct the negative nitrogen balance and hence the calcium
disturbance by the use of androgens and estrogens have not been very successful
in this patient. Calcium has also been given with no change in the X-ray findings
although the serum calcium has risen. The difficulty in applying any orthopedic
FIG. 3b
device to pemphigus-affected skin accentuates this patient's problem. His prompt
relapses on complete cessation of cortisone impels us to continue the hormone
with great misgivings. This additional danger of steroid therapy must be taken
into account when administering ACTH or cortisone for any length of time,
particularly in more or less elective cases.
SUMMARY
1. A case of osteoporosis and compression defects of the spine in a pemphigus
patient following prolonged ACTH and cortisone therapy is presented.
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2. This serious side effect must be watched for ia any patient where long
term corticosteroid therapy is employed.
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